Levito Lifesciencesprivate Limited
Levito Lifesciencesprivate Limited is a Private Non-govt company company incorporated in 2018 and based in Gujarat, India. It was founded by Deeva. Levito Lifesciencesprivate Limited operates in Medical & Precision (NIC 33309) with authorized capital of ₹10.00 L and paid-up capital of ₹1.00 L. For 2021-22, the company reported revenue of ₹0 and a net loss of ₹1.17 L. The board has 1 active director. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
1 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 21 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +31d | filed |
| MGT-7 | FY2023-24 | 20 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 24 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Levito Lifesciencesprivate Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 683647491 | HDFC Bank Ltd(Bank) | ₹14.76 Cr | 19 Sep 2021 | Satisfied |
| 910946451 | Axis Bank Ltd(Bank) | ₹20.04 Cr | 19 Sep 2023 | Satisfied |
| 402065251 | State Bank of India(Bank) | ₹12.91 Cr | 12 Mar 2022 | Satisfied |
| 919364037 | HDFC Bank Ltd(Bank) | ₹22.50 Cr | 19 Sep 2019 | Satisfied |
| 498781578 | Kotak Mahindra Bank Ltd(Bank) | ₹6.10 Cr | 04 Jul 2023 | Satisfied |
| 684350093 | ICICI Bank Ltd(Bank) | ₹22.37 Cr | 19 Sep 2023 | Open |
Charge IDs, lenders & amounts for Levito Lifesciencesprivate Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2019-20 | — |
Detailed Financials
3 FYs| Line item | 2021-22 | 2020-21 | 2019-20 |
|---|---|---|---|
| Income statement | |||
| Revenue from operations | |||
| Other income | |||
| Total income | |||
| Total expenses | |||
| Profit before tax | |||
| Profit / (Loss) after tax | |||
| Balance sheet | |||
| Equity / Net worth | |||
| Borrowings | |||
| Current liabilities | |||
| Total liabilities | |||
| Current assets | |||
| Cash & equivalents | |||
| Total assets | |||
| Employees | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2021-22 | — | — | — | |
| Profit after Tax2021-22 | — | — | — | |
| Net Worth2021-22 | — | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2019-20 | — | — | -26.97% | -26.97% | 1.00 | |||
| 2020-21 | — | — | — | -179.06% | — | |||
| 2021-22 | — | — | — | -86.10% | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 1,31,63,170 | 65.27% |
| Institutional Investors | 2 | 22,29,758 | 11.06% |
| Public & Others | 53 | 47,74,102 | 23.67% |
Promoter, institutional & public holding for Levito Lifesciencesprivate Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
35 peersEvents & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.